Selvita SA SELVITA ORD SHS/ PLSELVT00013 /
- - | Chg. - | Volume | Bid06:00:11 | Ask06:00:11 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-PLN | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 1.23 bill.PLN | - | - |
GlobeNewswire
11/12/2023
Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire
07/12/2023
Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire
29/11/2023
Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
23/10/2023
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire
04/10/2023
Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire
13/09/2023
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update